Amit Bhalla serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Amit Bhalla has executed 18 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 30, 2022 involved receiving (via award) 1,250 shares valued at $0.
Amit Bhalla currently holds 71,818 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amit Bhalla has been a net neutral trader of NAVB stock. They have purchased $0 and sold $0 worth of shares.
Amit Bhalla's most recent insider trade was on Nov 30, 2022, when they sold 1,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 30, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Aug 31, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Jul 31, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Jun 30, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| May 31, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Apr 30, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Mar 31, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Feb 28, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Jan 31, 2022 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Dec 31, 2021 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Nov 30, 2021 | NAVB | $0 | Award | 1,250 | $N/A | Discretionary |
| Nov 15, 2021 | NAVB | $0 | Award | 30,000 | $N/A | Discretionary |
| Nov 15, 2021 | NAVB | $0 | Award | 2,623 | $N/A | Discretionary |
| Sep 30, 2021 | NAVB | $0 | Award | 4,286 | $N/A | Discretionary |
| Jun 30, 2021 | NAVB | $0 | Award | 2,409 | $N/A | Discretionary |
| May 4, 2021 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |